

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 7.60478388 |
| 2 | actin nucleation (GO:0045010) | 7.43885329 |
| 3 | sequestering of actin monomers (GO:0042989) | 7.36399349 |
| 4 | response to pheromone (GO:0019236) | 6.68840124 |
| 5 | cytidine metabolic process (GO:0046087) | 5.91857495 |
| 6 | cytidine catabolic process (GO:0006216) | 5.91857495 |
| 7 | cytidine deamination (GO:0009972) | 5.91857495 |
| 8 | regulation of glucokinase activity (GO:0033131) | 5.69616584 |
| 9 | regulation of hexokinase activity (GO:1903299) | 5.69616584 |
| 10 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.22226940 |
| 11 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 5.00324440 |
| 12 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.93413803 |
| 13 | DNA deamination (GO:0045006) | 4.92358655 |
| 14 | positive regulation of lamellipodium assembly (GO:0010592) | 4.64194047 |
| 15 | natural killer cell differentiation (GO:0001779) | 4.62587247 |
| 16 | glycerol metabolic process (GO:0006071) | 4.56826715 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.38070659 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.33114982 |
| 19 | regulation of natural killer cell differentiation (GO:0032823) | 4.27351909 |
| 20 | positive regulation of lamellipodium organization (GO:1902745) | 4.16202594 |
| 21 | myoblast migration (GO:0051451) | 4.07214565 |
| 22 | alditol metabolic process (GO:0019400) | 3.95835084 |
| 23 | cellular response to zinc ion (GO:0071294) | 3.87414173 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.67448505 |
| 25 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.64610461 |
| 26 | regulation of regulatory T cell differentiation (GO:0045589) | 3.46546764 |
| 27 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.43238592 |
| 28 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.41772058 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.36708997 |
| 30 | regulation of T cell tolerance induction (GO:0002664) | 3.35329259 |
| 31 | cellular response to cadmium ion (GO:0071276) | 3.29860690 |
| 32 | protein targeting to Golgi (GO:0000042) | 3.27262901 |
| 33 | positive regulation of tolerance induction (GO:0002645) | 3.25155767 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.23910959 |
| 35 | negative regulation of T cell apoptotic process (GO:0070233) | 3.23841671 |
| 36 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.18792974 |
| 37 | establishment of protein localization to Golgi (GO:0072600) | 3.18438481 |
| 38 | regulation of glucocorticoid secretion (GO:2000849) | 3.17971067 |
| 39 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17152076 |
| 40 | endocrine pancreas development (GO:0031018) | 3.15293796 |
| 41 | keratinocyte development (GO:0003334) | 3.12276153 |
| 42 | regulation of lamellipodium assembly (GO:0010591) | 3.05974672 |
| 43 | protein neddylation (GO:0045116) | 3.03786884 |
| 44 | ATP synthesis coupled proton transport (GO:0015986) | 3.01851629 |
| 45 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.01851629 |
| 46 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.00525144 |
| 47 | platelet dense granule organization (GO:0060155) | 2.96701726 |
| 48 | xenobiotic catabolic process (GO:0042178) | 2.95926052 |
| 49 | positive regulation of interleukin-17 production (GO:0032740) | 2.93128868 |
| 50 | T cell receptor signaling pathway (GO:0050852) | 2.86076922 |
| 51 | L-phenylalanine catabolic process (GO:0006559) | 2.85136583 |
| 52 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.85136583 |
| 53 | regulation of activation of Janus kinase activity (GO:0010533) | 2.83781926 |
| 54 | positive T cell selection (GO:0043368) | 2.82522704 |
| 55 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.81520346 |
| 56 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.79324837 |
| 57 | adaptation of signaling pathway (GO:0023058) | 2.79275332 |
| 58 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.79166371 |
| 59 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.78704326 |
| 60 | positive regulation of actin filament polymerization (GO:0030838) | 2.78012613 |
| 61 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.77674261 |
| 62 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.76822915 |
| 63 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.75619498 |
| 64 | L-phenylalanine metabolic process (GO:0006558) | 2.75619498 |
| 65 | piRNA metabolic process (GO:0034587) | 2.72289041 |
| 66 | lactate metabolic process (GO:0006089) | 2.72138011 |
| 67 | cytokine biosynthetic process (GO:0042089) | 2.71399378 |
| 68 | ribosomal small subunit assembly (GO:0000028) | 2.70853846 |
| 69 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.69723262 |
| 70 | detection of light stimulus involved in visual perception (GO:0050908) | 2.66074550 |
| 71 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.66074550 |
| 72 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.65699316 |
| 73 | ATP biosynthetic process (GO:0006754) | 2.65043387 |
| 74 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.63155422 |
| 75 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.61550151 |
| 76 | regulation of lamellipodium organization (GO:1902743) | 2.61276004 |
| 77 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.59692194 |
| 78 | regulation of tolerance induction (GO:0002643) | 2.59669502 |
| 79 | regulation of male gonad development (GO:2000018) | 2.58768627 |
| 80 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.57748744 |
| 81 | rhodopsin mediated signaling pathway (GO:0016056) | 2.57576107 |
| 82 | regulation of proton transport (GO:0010155) | 2.57420293 |
| 83 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.55856132 |
| 84 | RNA destabilization (GO:0050779) | 2.53886523 |
| 85 | sperm motility (GO:0030317) | 2.53153113 |
| 86 | regulation of cholesterol esterification (GO:0010872) | 2.52849148 |
| 87 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.50604565 |
| 88 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.49544991 |
| 89 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.48797708 |
| 90 | negative regulation of Notch signaling pathway (GO:0045746) | 2.44950683 |
| 91 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.44873881 |
| 92 | regulation of cardioblast proliferation (GO:0003264) | 2.44626389 |
| 93 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.44626389 |
| 94 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.44409854 |
| 95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.44157044 |
| 96 | electron transport chain (GO:0022900) | 2.42474920 |
| 97 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.42460648 |
| 98 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.41511098 |
| 99 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.41307792 |
| 100 | adenine nucleotide transport (GO:0051503) | 2.39867852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 9.09150108 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 5.39242216 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.26227856 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.99292364 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.92540335 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.33974567 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.12642355 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.35975304 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.31301832 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.15729821 |
| 11 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.97357869 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.89246539 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86464039 |
| 14 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47167541 |
| 15 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47167541 |
| 16 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46115062 |
| 17 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.45338177 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 1.43141190 |
| 19 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.41211995 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.35498262 |
| 21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35031739 |
| 22 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.34490721 |
| 23 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.33995099 |
| 24 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.31488909 |
| 25 | AR_20517297_ChIP-Seq_VCAP_Human | 1.30371747 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29527908 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29342416 |
| 28 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.27286725 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.27119902 |
| 30 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25400826 |
| 31 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.22354015 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22266974 |
| 33 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.22029988 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.21335567 |
| 35 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.20777054 |
| 36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.19154665 |
| 37 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19073546 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18210681 |
| 39 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.17520474 |
| 40 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.15100424 |
| 41 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.14919856 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13238942 |
| 43 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11196307 |
| 44 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.11099089 |
| 45 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.09179449 |
| 46 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.07242761 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06913690 |
| 48 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06344148 |
| 49 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.05439850 |
| 50 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.04028680 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03727887 |
| 52 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03687660 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03175732 |
| 54 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.00073693 |
| 55 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98872652 |
| 56 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.98421448 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.97918816 |
| 58 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.97648738 |
| 59 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97526252 |
| 60 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97526252 |
| 61 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.94732396 |
| 62 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.94732396 |
| 63 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.94421374 |
| 64 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.92599605 |
| 65 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.92070695 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 0.90656315 |
| 67 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89458918 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89158704 |
| 69 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.88494045 |
| 70 | * ERA_21632823_ChIP-Seq_H3396_Human | 0.87688555 |
| 71 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.86675689 |
| 72 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.86213101 |
| 73 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.85222669 |
| 74 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.84640972 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84228586 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.83540173 |
| 77 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80940477 |
| 78 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.80518477 |
| 79 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.80056549 |
| 80 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.79963843 |
| 81 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79483658 |
| 82 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.78414661 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 0.78110423 |
| 84 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.77428945 |
| 85 | MAF_26560356_Chip-Seq_TH2_Human | 0.77170070 |
| 86 | SA1_27219007_Chip-Seq_Bcells_Human | 0.77000305 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76778886 |
| 88 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76772053 |
| 89 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.76335815 |
| 90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.75623295 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75623295 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.75583930 |
| 93 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.74867969 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.74826361 |
| 95 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74308516 |
| 96 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.73744598 |
| 97 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.73395035 |
| 98 | UTX_26944678_Chip-Seq_JUKART_Human | 0.72467396 |
| 99 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.71832813 |
| 100 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.71813663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005379_endocrine/exocrine_gland_phen | 3.50692465 |
| 2 | MP0002638_abnormal_pupillary_reflex | 3.13546952 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.07344738 |
| 4 | MP0009840_abnormal_foam_cell | 3.01494908 |
| 5 | MP0009333_abnormal_splenocyte_physiolog | 2.91760764 |
| 6 | MP0001661_extended_life_span | 2.80574700 |
| 7 | MP0005671_abnormal_response_to | 2.66120719 |
| 8 | MP0002102_abnormal_ear_morphology | 2.61153005 |
| 9 | MP0001348_abnormal_lacrimal_gland | 2.51365410 |
| 10 | MP0005410_abnormal_fertilization | 2.33265931 |
| 11 | MP0003195_calcinosis | 2.19784587 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.09686299 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.01844482 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.01727491 |
| 15 | MP0003786_premature_aging | 1.99345645 |
| 16 | MP0008961_abnormal_basal_metabolism | 1.98365531 |
| 17 | MP0003879_abnormal_hair_cell | 1.97522419 |
| 18 | MP0009785_altered_susceptibility_to | 1.95306886 |
| 19 | MP0005670_abnormal_white_adipose | 1.86874648 |
| 20 | MP0002693_abnormal_pancreas_physiology | 1.84833116 |
| 21 | MP0004043_abnormal_pH_regulation | 1.80667674 |
| 22 | MP0001968_abnormal_touch/_nociception | 1.75943689 |
| 23 | MP0004134_abnormal_chest_morphology | 1.72895369 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.69764264 |
| 25 | MP0002909_abnormal_adrenal_gland | 1.66486669 |
| 26 | MP0004381_abnormal_hair_follicle | 1.66073754 |
| 27 | MP0005257_abnormal_intraocular_pressure | 1.64046020 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 1.63784068 |
| 29 | MP0005000_abnormal_immune_tolerance | 1.63022968 |
| 30 | MP0005075_abnormal_melanosome_morpholog | 1.62586932 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.60660073 |
| 32 | MP0008872_abnormal_physiological_respon | 1.58503985 |
| 33 | MP0002006_tumorigenesis | 1.52905395 |
| 34 | MP0005387_immune_system_phenotype | 1.50552516 |
| 35 | MP0001790_abnormal_immune_system | 1.50552516 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.49606806 |
| 37 | MP0003718_maternal_effect | 1.48452189 |
| 38 | MP0004883_abnormal_blood_vessel | 1.47548527 |
| 39 | MP0001905_abnormal_dopamine_level | 1.45166102 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.42130060 |
| 41 | MP0005551_abnormal_eye_electrophysiolog | 1.41774081 |
| 42 | MP0000604_amyloidosis | 1.39243375 |
| 43 | MP0006072_abnormal_retinal_apoptosis | 1.36668206 |
| 44 | MP0002723_abnormal_immune_serum | 1.34273717 |
| 45 | MP0003646_muscle_fatigue | 1.30626852 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.28221312 |
| 47 | MP0005535_abnormal_body_temperature | 1.24253208 |
| 48 | MP0002933_joint_inflammation | 1.22175683 |
| 49 | MP0008877_abnormal_DNA_methylation | 1.22055544 |
| 50 | MP0001879_abnormal_lymphatic_vessel | 1.19548913 |
| 51 | MP0005025_abnormal_response_to | 1.19185957 |
| 52 | MP0001800_abnormal_humoral_immune | 1.16254779 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 1.15419587 |
| 54 | MP0001944_abnormal_pancreas_morphology | 1.14913482 |
| 55 | MP0005164_abnormal_response_to | 1.09671084 |
| 56 | MP0003878_abnormal_ear_physiology | 1.08446626 |
| 57 | MP0005377_hearing/vestibular/ear_phenot | 1.08446626 |
| 58 | MP0009643_abnormal_urine_homeostasis | 1.07695561 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 1.07516385 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.07464909 |
| 61 | MP0003252_abnormal_bile_duct | 1.05415381 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.04858247 |
| 63 | MP0009697_abnormal_copulation | 1.04519442 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.04222462 |
| 65 | MP0001666_abnormal_nutrient_absorption | 1.04210125 |
| 66 | MP0010234_abnormal_vibrissa_follicle | 1.00664381 |
| 67 | MP0000685_abnormal_immune_system | 0.99182375 |
| 68 | MP0001819_abnormal_immune_cell | 0.97087772 |
| 69 | MP0005360_urolithiasis | 0.96805447 |
| 70 | MP0008007_abnormal_cellular_replicative | 0.94771731 |
| 71 | MP0001764_abnormal_homeostasis | 0.93931665 |
| 72 | MP0001984_abnormal_olfaction | 0.93841371 |
| 73 | MP0001845_abnormal_inflammatory_respons | 0.91589027 |
| 74 | MP0005253_abnormal_eye_physiology | 0.91267190 |
| 75 | MP0009745_abnormal_behavioral_response | 0.90486196 |
| 76 | MP0005448_abnormal_energy_balance | 0.90068343 |
| 77 | MP0001765_abnormal_ion_homeostasis | 0.89911893 |
| 78 | MP0003698_abnormal_male_reproductive | 0.89708975 |
| 79 | MP0000467_abnormal_esophagus_morphology | 0.89631898 |
| 80 | MP0002557_abnormal_social/conspecific_i | 0.89371986 |
| 81 | MP0002090_abnormal_vision | 0.88870054 |
| 82 | MP0005646_abnormal_pituitary_gland | 0.87999083 |
| 83 | MP0000230_abnormal_systemic_arterial | 0.87919141 |
| 84 | MP0001929_abnormal_gametogenesis | 0.87271239 |
| 85 | MP0001853_heart_inflammation | 0.86021583 |
| 86 | MP0008469_abnormal_protein_level | 0.85894856 |
| 87 | MP0006082_CNS_inflammation | 0.85804286 |
| 88 | MP0002452_abnormal_antigen_presenting | 0.85496714 |
| 89 | MP0000427_abnormal_hair_cycle | 0.84242378 |
| 90 | MP0000609_abnormal_liver_physiology | 0.83690654 |
| 91 | MP0002118_abnormal_lipid_homeostasis | 0.83635013 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.81035408 |
| 93 | MP0005332_abnormal_amino_acid | 0.79094640 |
| 94 | MP0003011_delayed_dark_adaptation | 0.78909543 |
| 95 | MP0001756_abnormal_urination | 0.78184674 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.78121787 |
| 97 | MP0002970_abnormal_white_adipose | 0.77365056 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.77237105 |
| 99 | MP0005085_abnormal_gallbladder_physiolo | 0.77117448 |
| 100 | MP0001243_abnormal_dermal_layer | 0.76608837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic seizures (HP:0002173) | 6.33701923 |
| 2 | Ketoacidosis (HP:0001993) | 5.33589953 |
| 3 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.73697157 |
| 4 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.73697157 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.35579474 |
| 6 | Generalized aminoaciduria (HP:0002909) | 4.19039579 |
| 7 | Ketosis (HP:0001946) | 4.18914349 |
| 8 | Symptomatic seizures (HP:0011145) | 4.05998616 |
| 9 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.87220558 |
| 10 | Renal Fanconi syndrome (HP:0001994) | 3.79381455 |
| 11 | Glycosuria (HP:0003076) | 3.37324939 |
| 12 | Abnormality of urine glucose concentration (HP:0011016) | 3.37324939 |
| 13 | Hypoglycemic coma (HP:0001325) | 3.34956387 |
| 14 | Late onset (HP:0003584) | 3.32257393 |
| 15 | Severe visual impairment (HP:0001141) | 3.30268365 |
| 16 | Congenital stationary night blindness (HP:0007642) | 3.22849304 |
| 17 | Thyroiditis (HP:0100646) | 3.14421781 |
| 18 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.05623036 |
| 19 | Recurrent corneal erosions (HP:0000495) | 2.99764118 |
| 20 | Mitochondrial inheritance (HP:0001427) | 2.96473950 |
| 21 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.93019295 |
| 22 | Prostate neoplasm (HP:0100787) | 2.87469951 |
| 23 | Alacrima (HP:0000522) | 2.85514618 |
| 24 | Abnormality of dental color (HP:0011073) | 2.82456582 |
| 25 | Aplasia of the musculature (HP:0100854) | 2.78924743 |
| 26 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.78199963 |
| 27 | Orthostatic hypotension (HP:0001278) | 2.76530884 |
| 28 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.75620863 |
| 29 | Abnormality of chromosome stability (HP:0003220) | 2.75119813 |
| 30 | Hyperphosphaturia (HP:0003109) | 2.74959690 |
| 31 | Tubulointerstitial nephritis (HP:0001970) | 2.72707836 |
| 32 | T lymphocytopenia (HP:0005403) | 2.66888084 |
| 33 | Abnormality of T cell number (HP:0011839) | 2.66839641 |
| 34 | Increased hepatocellular lipid droplets (HP:0006565) | 2.65198572 |
| 35 | Abnormality of the fovea (HP:0000493) | 2.65147288 |
| 36 | Central scotoma (HP:0000603) | 2.54752841 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 2.54085730 |
| 38 | Progressive macrocephaly (HP:0004481) | 2.52393174 |
| 39 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.47678529 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.46543082 |
| 41 | Chorioretinal atrophy (HP:0000533) | 2.43986385 |
| 42 | Partial duplication of the phalanx of hand (HP:0009999) | 2.40607401 |
| 43 | Abnormality of renal resorption (HP:0011038) | 2.40271264 |
| 44 | Renal cortical cysts (HP:0000803) | 2.39431809 |
| 45 | Hepatic necrosis (HP:0002605) | 2.38273435 |
| 46 | Partial duplication of thumb phalanx (HP:0009944) | 2.34764500 |
| 47 | Abnormality of macular pigmentation (HP:0008002) | 2.29925562 |
| 48 | Spontaneous abortion (HP:0005268) | 2.28639438 |
| 49 | Lipid accumulation in hepatocytes (HP:0006561) | 2.27675595 |
| 50 | Hyperglycemia (HP:0003074) | 2.27319920 |
| 51 | Amyotrophic lateral sclerosis (HP:0007354) | 2.25510450 |
| 52 | Insulin resistance (HP:0000855) | 2.24989632 |
| 53 | Autoimmune hemolytic anemia (HP:0001890) | 2.24616537 |
| 54 | Complement deficiency (HP:0004431) | 2.23218758 |
| 55 | Abnormal urine phosphate concentration (HP:0012599) | 2.21803391 |
| 56 | Attenuation of retinal blood vessels (HP:0007843) | 2.20369674 |
| 57 | Decreased lacrimation (HP:0000633) | 2.15453222 |
| 58 | Hypophosphatemic rickets (HP:0004912) | 2.12098230 |
| 59 | Stomatitis (HP:0010280) | 2.11085855 |
| 60 | Chronic hepatic failure (HP:0100626) | 2.07118241 |
| 61 | Increased CSF lactate (HP:0002490) | 2.06137001 |
| 62 | Severe combined immunodeficiency (HP:0004430) | 2.05809151 |
| 63 | Abolished electroretinogram (ERG) (HP:0000550) | 2.04214162 |
| 64 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.02740979 |
| 65 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.02740979 |
| 66 | Pendular nystagmus (HP:0012043) | 2.00512107 |
| 67 | Facial shape deformation (HP:0011334) | 1.99914791 |
| 68 | Potter facies (HP:0002009) | 1.99914791 |
| 69 | Retinal atrophy (HP:0001105) | 1.99734707 |
| 70 | Metaphyseal dysplasia (HP:0100255) | 1.98707667 |
| 71 | Absent thumb (HP:0009777) | 1.97369366 |
| 72 | Male infertility (HP:0003251) | 1.97319464 |
| 73 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.97169971 |
| 74 | Abnormality of the preputium (HP:0100587) | 1.96983601 |
| 75 | Hyperlipoproteinemia (HP:0010980) | 1.96657237 |
| 76 | Exertional dyspnea (HP:0002875) | 1.96418422 |
| 77 | Increased intramyocellular lipid droplets (HP:0012240) | 1.94188785 |
| 78 | Small epiphyses (HP:0010585) | 1.93266211 |
| 79 | Acute encephalopathy (HP:0006846) | 1.88357687 |
| 80 | Abnormality of eosinophils (HP:0001879) | 1.87275904 |
| 81 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.86548518 |
| 82 | Osteomalacia (HP:0002749) | 1.80186934 |
| 83 | Abnormal sex determination (HP:0012244) | 1.79982985 |
| 84 | Sex reversal (HP:0012245) | 1.79982985 |
| 85 | Brushfield spots (HP:0001088) | 1.79362488 |
| 86 | Decreased central vision (HP:0007663) | 1.78987889 |
| 87 | Increased muscle lipid content (HP:0009058) | 1.77771347 |
| 88 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.75993521 |
| 89 | Agitation (HP:0000713) | 1.75212511 |
| 90 | Leukocytosis (HP:0001974) | 1.75115096 |
| 91 | Azoospermia (HP:0000027) | 1.74421765 |
| 92 | Cerebral edema (HP:0002181) | 1.73636300 |
| 93 | Increased IgE level (HP:0003212) | 1.72516565 |
| 94 | Hypoplasia of the pons (HP:0012110) | 1.71002760 |
| 95 | Hypoplasia of the fovea (HP:0007750) | 1.70392656 |
| 96 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.70392656 |
| 97 | Sparse lateral eyebrow (HP:0005338) | 1.69724127 |
| 98 | Abnormality of the costochondral junction (HP:0000919) | 1.68243206 |
| 99 | Exocrine pancreatic insufficiency (HP:0001738) | 1.64597745 |
| 100 | Type I diabetes mellitus (HP:0100651) | 1.64097748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 5.24147768 |
| 2 | PASK | 3.89481675 |
| 3 | MAP3K12 | 3.66962268 |
| 4 | TLK1 | 3.57209107 |
| 5 | FRK | 3.27912120 |
| 6 | STK16 | 2.96343258 |
| 7 | PINK1 | 2.90299079 |
| 8 | ADRBK2 | 2.52489125 |
| 9 | TESK2 | 2.52462228 |
| 10 | PLK4 | 2.33692262 |
| 11 | TESK1 | 2.30687234 |
| 12 | BCKDK | 2.18879564 |
| 13 | ZAK | 2.13089999 |
| 14 | MST4 | 1.97503401 |
| 15 | LIMK1 | 1.94158377 |
| 16 | GRK7 | 1.88205829 |
| 17 | STK39 | 1.84745671 |
| 18 | INSRR | 1.79259766 |
| 19 | ACVR1B | 1.78199336 |
| 20 | MYLK | 1.75452333 |
| 21 | VRK1 | 1.66364416 |
| 22 | TAOK2 | 1.63498096 |
| 23 | NLK | 1.48641427 |
| 24 | EPHB1 | 1.42190843 |
| 25 | TIE1 | 1.39144663 |
| 26 | JAK1 | 1.33187282 |
| 27 | TBK1 | 1.30532360 |
| 28 | MAP4K2 | 1.26450039 |
| 29 | WNK4 | 1.23704685 |
| 30 | GRK1 | 1.18262984 |
| 31 | FES | 1.17687246 |
| 32 | SCYL2 | 1.14943017 |
| 33 | IKBKE | 1.12073214 |
| 34 | VRK2 | 1.10847745 |
| 35 | MAP3K3 | 1.06746980 |
| 36 | MAP3K11 | 1.06603605 |
| 37 | ITK | 1.01912202 |
| 38 | PRPF4B | 1.01690010 |
| 39 | ZAP70 | 1.00285607 |
| 40 | OBSCN | 0.99971857 |
| 41 | EPHA3 | 0.97672902 |
| 42 | ROCK1 | 0.93652520 |
| 43 | ADRBK1 | 0.91904383 |
| 44 | PRKCQ | 0.90100039 |
| 45 | TRPM7 | 0.88465750 |
| 46 | OXSR1 | 0.83671803 |
| 47 | AKT3 | 0.81949313 |
| 48 | STK24 | 0.80469752 |
| 49 | CAMKK1 | 0.80044206 |
| 50 | TNIK | 0.77888587 |
| 51 | PAK1 | 0.75479857 |
| 52 | CASK | 0.74681870 |
| 53 | PRKG2 | 0.72165006 |
| 54 | MAP3K1 | 0.70468045 |
| 55 | BMX | 0.70214785 |
| 56 | PLK2 | 0.68829749 |
| 57 | DAPK3 | 0.64140687 |
| 58 | FER | 0.62504350 |
| 59 | PAK3 | 0.59004099 |
| 60 | LCK | 0.58860923 |
| 61 | SGK2 | 0.58732442 |
| 62 | CSK | 0.58644857 |
| 63 | PTK2B | 0.58415586 |
| 64 | RPS6KA5 | 0.57448658 |
| 65 | PAK4 | 0.55901962 |
| 66 | BMPR1B | 0.55850205 |
| 67 | PIK3CG | 0.54241404 |
| 68 | HIPK2 | 0.53830330 |
| 69 | TAOK1 | 0.51989445 |
| 70 | IKBKB | 0.49470432 |
| 71 | TRIM28 | 0.49299042 |
| 72 | RPS6KA4 | 0.49205253 |
| 73 | SYK | 0.49131041 |
| 74 | AURKA | 0.48623965 |
| 75 | PRKCI | 0.40514503 |
| 76 | FGFR2 | 0.38966352 |
| 77 | WNK3 | 0.38899042 |
| 78 | FGFR3 | 0.38581230 |
| 79 | MAP3K9 | 0.38096925 |
| 80 | PDGFRB | 0.37343611 |
| 81 | PRKCA | 0.36853407 |
| 82 | SGK494 | 0.36256778 |
| 83 | SGK223 | 0.36256778 |
| 84 | GRK6 | 0.35456894 |
| 85 | LMTK2 | 0.33859196 |
| 86 | MAPKAPK5 | 0.33074914 |
| 87 | CAMK2A | 0.31690453 |
| 88 | DMPK | 0.29723728 |
| 89 | PKN1 | 0.27871883 |
| 90 | PRKCH | 0.27711375 |
| 91 | EGFR | 0.26301548 |
| 92 | CSNK1G3 | 0.26288046 |
| 93 | PRKACA | 0.25576509 |
| 94 | CSNK1G1 | 0.25058274 |
| 95 | TYK2 | 0.24769026 |
| 96 | PIM1 | 0.24479157 |
| 97 | BRD4 | 0.24263136 |
| 98 | AKT2 | 0.22922374 |
| 99 | PRKCE | 0.21749857 |
| 100 | PRKCG | 0.19956517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.70360772 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.63065533 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.87627392 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.81452802 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.56037933 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.53524893 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.40245478 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.17997703 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.14553403 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.09638508 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.06794273 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.85743619 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.84672398 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.82947742 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74550438 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.69206272 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.68489590 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.63528689 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.63291163 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63267294 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.55341570 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.51779637 |
| 23 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39564319 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31173827 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.31040652 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30778616 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.26199898 |
| 28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25234547 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24594502 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.23653390 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21743270 |
| 32 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.20820049 |
| 33 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.14210545 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.13942897 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13756697 |
| 36 | Mineral absorption_Homo sapiens_hsa04978 | 1.13362814 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.11984792 |
| 38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11931643 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07786041 |
| 40 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06960176 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.06086348 |
| 42 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01983240 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.99472987 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.97762092 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.95495738 |
| 46 | Homologous recombination_Homo sapiens_hsa03440 | 0.90771831 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88126468 |
| 48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.86577536 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86222029 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 0.84435002 |
| 51 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.83162106 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82817637 |
| 53 | Ribosome_Homo sapiens_hsa03010 | 0.82688382 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.82322883 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82013171 |
| 56 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.80962316 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79876230 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79274720 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.76961642 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75761606 |
| 61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74684638 |
| 62 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.73988372 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73487808 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71756498 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71669330 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71603262 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.70832607 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70467570 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70404490 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69000966 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68412965 |
| 72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65762996 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65712067 |
| 74 | Basal transcription factors_Homo sapiens_hsa03022 | 0.64133024 |
| 75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61643196 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61076202 |
| 77 | RNA polymerase_Homo sapiens_hsa03020 | 0.60987392 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58997169 |
| 79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55068479 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51953588 |
| 81 | Base excision repair_Homo sapiens_hsa03410 | 0.51729867 |
| 82 | Malaria_Homo sapiens_hsa05144 | 0.49930984 |
| 83 | Taste transduction_Homo sapiens_hsa04742 | 0.48704479 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48313293 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47326275 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45789115 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45532271 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.45338837 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43163759 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42868206 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41468277 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.40605289 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.39060754 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38333318 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.37704075 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.36956854 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.36731595 |
| 98 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.36307622 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.35573955 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.35197608 |

